en · de · es · fr · pt
sr9009-notes.peptides6088.com › Wiki › Identity, Handling, And Regulation — Evidence Review

Identity, Handling, And Regulation — Evidence Review

By Editorial Desk · published 2025-10-11 · last reviewed 2025-11-04 · Wiki

The short version of LC-MS/MS fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-11-04 and is reviewed periodically as new material appears.

Identity, Handling, and Regulation

Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.

In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.

Detection, Regulation, and Misconceptions

Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.

Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.

Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.

Sr9009 at a glance

PropertyValueNotes
AppearanceWhite to off-white solidVisual inspection is not sufficient for identity.
SolubilitySoluble in DMSO and ethanolLow solubility in water.
Typical storage-20 °C, desiccated, darkProtect from repeated temperature changes.
Common analytical methodLC-MS or HPLC-UVReference standard required for comparison.
Common synonymsSR9009; Stenabolic; REV-ERB agonistVendor naming may vary.

Analytical Detection and Stability

Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.

Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.

Related pages on this site

SR9009 Identity and Mechanism

SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.

SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.

Background and Mechanism of SR9009

SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.

SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.

Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.

Reference notes

Nicotinamide riboside (NR) is utilized through an additional pathway involving phosphorylation by the nicotinamide riboside kinase enzymes (NRK1 and NRK2). In yeasts, NR has also been shown to be degraded by the nucleosidases Pnp1, Urh1 and Meu1, before being converted to NAD via the Preiss-Handler pathway and the action of the nicotinamidase Pnc1.

=== General === Peter Atkins & Julio de Paula, 2006, "Physical chemistry," 8th Edn., New York, NY, USA:Macmillan, ISBN 0716787598, accessed 21 June 2015. [E.g., see p. 422 for a group theoretical/symmetry description of atomic orbitals contributing to bonding in methane, CH4, and pp. 390f for estimation of π-electron binding energy for 1,3-butadiene by the Hückel method.] Thomas H. Lowry & Kathleen Schueller Richardson, 1987, Mechanism and Theory in Organic Chemistry, 3rd Edn., New York, NY, USA:Harper & Row, ISBN 0060440848, accessed 20 June 2015. [The authoritative textbook on the subject, containing a number of appendices that provide technical details on molecular orbital theory, kinetic isotope effects, transition state theory, and radical chemistry.] Eric V. Anslyn & Dennis A. Dougherty, 2006, Modern Physical Organic Chemistry, Sausalito, Calif.: University Science Books, ISBN 1891389319. [A modernized and streamlined treatment with an emphasis on applications and cross-disciplinary connections.] Michael B. Smith & Jerry March, 2007, "March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure," 6th Ed., New York, NY, USA:Wiley & Sons, ISBN 0470084944, accessed 19 June 2015. Francis A. Carey & Richard J. Sundberg, 2006, "Advanced Organic Chemistry: Part A: Structure and Mechanisms," 4th Edn., New York, NY, USA:Springer Science & Business Media, ISBN 0306468565, accessed 19 June 2015. Hammett, Louis P. (1940) Physical Organic Chemistry, New York, NY, USA: McGraw Hill, accessed 20 June 2015.

They called for further research on the subject, as chlorpromazine is a cheap benchmark drug and one of the most used treatments for schizophrenia worldwide. Chlorpromazine has also been used in porphyria and as part of tetanus treatment. It is still recommended for short-term management of severe anxiety and psychotic aggression. Resistant and severe hiccups, severe nausea/emesis, and preanesthetic conditioning are other uses. Symptoms of delirium in hospitalized AIDS patients have been effectively treated with low doses of chlorpromazine.

Around the time, an expert concludes that "AI art is everywhere right now", with even experts not knowing what it will mean, a news outlet establishes that "AI-generated art booms" and reports about issues of copyright and automation of professional artists, a news outlet investigates how online communities (e.g. their rules) confronted with many such artworks react, a news outlet raised concerns over deepfakes, a magazine highlights possibilities of enabling "new forms of artistic expression", an editorial notes that it may be seen as a welcome "augmentation of human capability". Moreover, additional functionalities – such as enabling the use of user-provided concepts (like an object or a style) learned from few images for novel personalized art generated from the associated word/s (2 Aug) or expanding beyond the borders of artistic images in the same style (31 Aug) – are reported. On 22 August, Stable Diffusion is released as free and open source software.

Sources: en.wikipedia.org

Reference notes

== Structure == Lysine carboxypeptidase has a molecular weight of between 270 and 330 kDa (kilodaltons). It is a tetrameric glycoprotein. It is composed of two 83 kDa subunits and two active subunits between 55 kDa and 48 kDa and these are held together by non-covalent interactions. The 83 kDa subunits are regulatory and do not directly contribute to catalytic activity; they are also heavily glycosylated. These function to stabilize the active subunits and keep them in circulation. Catalytic functioning is retained when the 83 kDa subunits are eliminated from the active subunits, but they are still necessary for their support roles. The active subunits are small and relatively unstable at body temperature and blood pH, so they would not last long in the plasma without the regulatory subunits attached. The 55 kDa-48 kDa portions are both catalytically active. The primary structure of the 83 kDa subunit can be split into three main domains. The first domain is located at the N-terminus and consists of 52 amino acids with the first 27 being cysteine-rich. The second domain refers to the next 312 amino acids and it consists of 13 leucine-rich repeat (LRR) sections, each made up of 24 residues. The final C-terminal domain refers to the last 145 residues where amino acids 400-425 hold a cysteine-rich section. The secondary/tertiary structure of the subunit has not yet been experimentally determined, but it has been hypothesized based upon how other LRR proteins fold.

Anhydrous hydrogen bromide is a poor solvent, only able to dissolve small molecular compounds such as nitrosyl chloride and phenol, or salts with very low lattice energies such as tetraalkylammonium halides.

=== Aortic dissection === Fluoroquinolones can increase the rate of rare but serious tears in the aorta by 31% compared to other antibiotics. People at increased risk include those with aortic aneurysm, hypertension, certain genetic conditions such as Marfan syndrome and Ehlers–Danlos syndrome, and the elderly. For these people, fluoroquinolones should be used only when no other treatment options are available. One year after the warning announcement, prescribing behaviors were reported to have remained unchanged.

== Technology description == All living surfaces are decorated with a diverse range of complex molecules, which are key modulators of chemical communications and other functions such as protection, adhesion, infectivity, apoptosis, etc. Functional-Spacer-Lipid (FSL) Kode constructs can be synthesized to mimic the bioactive components present on biological surfaces, and then re-present them in novel ways. The architecture of an FSL Kode construct, as implicit in the name, consists of three components - a functional head group, a spacer, and a lipid tail. This structure is analogous to a Lego minifigure in that, they have three structural components, with each component having a separate purpose. In the examples shown in all the figures, a Lego 'minifig' has been used for the analogy. However, it should be appreciated that this is merely a representation and the true structural similarity is significantly varied between Lego minifigures and FSL Kode constructs (fig 1). The functional group of an FSL is equivalent to a Lego minifigure head, with both being at the extremity and carrying the character functional components. The spacer of the FSL is equivalent to the body of the Lego minifigure and the arms on the minifigure are representative of substitutions which may be engineered into the chemical makeup of the spacer. The lipid of the FSL anchors it to lipid membranes and gives the FSL construct its amphiphatic nature which can cause it to self-assemble. Because the lipid tail can act directly as an anchor it is analogous to the legs of a Lego minifigure.

The primary use for fresh water is to provide feedwater for the reactor and steam propulsion plants. It is also available for showers, sinks, cooking and cleaning once propulsion plant needs have been met. Seawater is used to flush toilets, and the resulting "blackwater" is stored in a sanitary tank until it is blown overboard using pressurized air or pumped overboard by using a special sanitary pump. The blackwater-discharge system requires skill to operate, and isolation valves must be closed before discharge. The German Type VIIC boat U-1206 was lost with casualties because of human error while using this system. Water from showers and sinks is stored separately in "grey water" tanks and discharged overboard using drain pumps. Trash on modern large submarines is usually disposed of using a tube called a Trash Disposal Unit (TDU), where it is compacted into a galvanized steel can. At the bottom of the TDU is a large ball valve. An ice plug is set on top of the ball valve to protect it, the cans atop the ice plug. The top breech door is shut, and the TDU is flooded and equalized with sea pressure, the ball valve is opened and the cans fall out assisted by scrap iron weights in the cans. The TDU is also flushed with seawater to ensure it is completely empty and the ball valve is clear before closing the valve.

Sources: en.wikipedia.org

Frequently asked questions

How is SR9009 usually analyzed?

Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.

What storage conditions are typical?

The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.

Is SR9009 legal to purchase?

Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.

Is SR9009 legal to buy?

Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.

Network